We are one of Australia’s flagship biomedical research institutes
Established in 2000, through investment from Griffith University and the Queensland State Government, we strive to be world leaders in developing next generation drugs, vaccines and diagnostics for diseases of global impact.
Our advantage is our focused approach towards drug, vaccine and diagnostic technology discovery and development using world-leading scientific expertise and dedication to discovering preventions and cures for a number of human diseases including infectious diseases and cancers.
The Institute boasts some of the world’s most renowned research leaders and state-of-the-art facilities. This rich research environment provides exceptional postgraduate education programs for the nation’s future scientists.
Dr Chris Davis
Having more than thirteen years management experience in innovation and commercialisation, working at the academic/industry interface, Chris' role is to lead a group of professionals dedicated to the strategic and operational development of the institute. As general manager, his prime focus is on translation and commercialisation of our scientific discoveries for social and economic benefit, locally and globally.
Chris has held a number of board positions. He is currently Deputy Chair of the Ausbiotech Ltd Qld Committee.
Gold Coast Health and Knowledge Precinct
Asia—Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health and Knowledge Precinct, is a unique global business location for industry development, research collaboration and jobs of the future.
Supported by $5 billion in infrastructure, including the world-class Griffith University and two major hospitals, the Precinct is transforming Australia’s leading lifestyle city. With a combination of expertise, infrastructure, land and lifestyle unique in Australia, nine hectares of greenfield land are available for health and innovation investment, serviced by the Gold Coast light rail and with easy transport access.
The Institute for Glycomics is the flagship Life Sciences institute within the GCHKP, which has a strong global investment attraction strategy for leading biotechnology companies, leveraging clinical research and trial opportunities with the co-located Gold Coast University Hospital and Gold Coast Private Hospital, as well as Menzies Health Institute Queensland.The GCHKP, which currently boasts almost 10,000 staff and more than 18,000 students, is set to employ over 26,000 people—11% of current Gold Coast jobs—generating gross value of $2.9 billion for the city’s economy.
The GCHKP hosts the Gold Coast 2018 Commonwealth Games Athletes Village, to evolve into a vibrant $550 million mixed-use community to live, work and learn, surrounded by seven hectares of parklands.
The Precinct is being developed in a unique partnership between all three levels of government and private investment, with a project office funded by City of Gold Coast, Griffith University and Gold Coast Health facilitating infrastructure development and investment attraction.The GCHKP represents a smart investment in Australia’s fastest growing major city, with a stable, diversifying economy, competitive taxes, skilled workforce and a climate and lifestyle second to none.Investment incentives are available.